NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
PHASE4CompletedINTERVENTIONAL
Enrollment
7
Participants
Timeline
Start Date
September 20, 2013
Primary Completion Date
December 12, 2015
Study Completion Date
December 12, 2015
Conditions
Fecal IncontinenceAnorectal Malformation
Interventions
DEVICE
NASHA/Dx (Solesta®)
Perianal submucosal injection of 3-4 ml of NASHA/Dx
All Listed Sponsors
lead
Uppsala University
OTHER
NCT03746834 - NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation | Biotech Hunter | Biotech Hunter